Literature DB >> 27872108

Nitrofurantoin, an Excellent Empiric Choice for Outpatient Cystitis.

Nicolas W Cortes-Penfield1, Barbara W Trautner2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27872108      PMCID: PMC5119046          DOI: 10.1128/AAC.01715-16

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  3 in total

1.  Managing uncomplicated urinary tract infection--making sense out of resistance data.

Authors:  Kalpana Gupta; Thomas M Hooton; Loren Miller
Journal:  Clin Infect Dis       Date:  2011-09-22       Impact factor: 9.079

Review 2.  International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases.

Authors:  Kalpana Gupta; Thomas M Hooton; Kurt G Naber; Björn Wullt; Richard Colgan; Loren G Miller; Gregory J Moran; Lindsay E Nicolle; Raul Raz; Anthony J Schaeffer; David E Soper
Journal:  Clin Infect Dis       Date:  2011-03-01       Impact factor: 9.079

3.  Antibiotic Resistance among Urinary Isolates from Female Outpatients in the United States in 2003 and 2012.

Authors:  Guillermo V Sanchez; Ahmed Babiker; Ronald N Master; Tony Luu; Anisha Mathur; Jose Bordon
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

  3 in total
  2 in total

1.  Reply to "Nitrofurantoin, an Excellent Empiric Choice for Outpatient Cystitis".

Authors:  Ahmed Babiker; Guillermo V Sanchez; Siddartha Bhandary; Jose M Bordon
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

Review 2.  Urinary Tract Infection and Asymptomatic Bacteriuria in Older Adults.

Authors:  Nicolas W Cortes-Penfield; Barbara W Trautner; Robin L P Jump
Journal:  Infect Dis Clin North Am       Date:  2017-12       Impact factor: 5.982

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.